Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
16.0%
% of FTXH's 51 holdings also in MEDI
21.6%
% of MEDI's 39 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus MEDI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in MEDI |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 6.9% | 10.5% | 6.9% |
|
PFIZER INC | 6.8% | 5.7% | 5.7% |
|
ELI LILLY & CO | 3.2% | 1.6% | 1.6% |
|
NEUROCRINE BIOSCIENCES INC | 1.5% | 1.1% | 1.1% |
|
INTRA-CELLULAR THERAPIES INC | 0.6% | 1.1% | 0.6% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to MEDI
|
BRISTOL-MYERS SQUIBB CO | 8.7% |
|
JOHNSON & JOHNSON | 6.9% |
|
MERCK & CO. INC. | 6.7% |
|
GILEAD SCIENCES INC | 4.5% |
|
CARDINAL HEALTH INC | 4.1% |
|
VIATRIS, INC. | 4.1% |
|
ZOETIS INC | 3.8% |
|
UNITED THERAPEUTICS CORP | 3.7% |
 |
JAZZ PHARMACEUTICALS PLC | 3.5% |
|
AMGEN INC | 3.1% |
FTXH Underweight Relative to MEDI
|
ASCENDIS PHARMA A/S | -14.2% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -7.7% |
|
MASIMO CORPORATION | -6.0% |
|
UNITEDHEALTH GROUP INC | -5.1% |
|
ABBVIE INC | -3.7% |
 |
SANOFI-AVENTIS-ADR | -3.6% |
|
OPTION CARE HEALTH INC | -3.5% |
|
VAXCYTE, INC. | -2.8% |
|
INNOVIVA, INC. | -2.8% |
|
ROCKET PHARMACEUTICALS, INC. | -2.7% |